Danny Bar-Zohar
Direttore Tecnico/Scientifico/R&S presso MERCK KGAA
Profilo
Danny Bar-Zohar is currently the Director at SwanBio Therapeutics, Inc. and the Head of Research & Development at Merck KGaA.
Previously, he served as the Global Head of Clinical Development & Analytics at Novartis Pharma AG from 2013 to 2020.
He also worked as a Partner at Syncona Partners LLP.
Dr. Bar-Zohar holds a doctorate degree from Sackler School of Medicine.
Posizioni attive di Danny Bar-Zohar
Società | Posizione | Inizio |
---|---|---|
MERCK KGAA | Direttore Tecnico/Scientifico/R&S | 01/03/2022 |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Direttore/Membro del Consiglio | 20/11/2020 |
Precedenti posizioni note di Danny Bar-Zohar
Società | Posizione | Fine |
---|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investitore di Private Equity | - |
Formazione di Danny Bar-Zohar
Sackler School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
MERCK KGAA | Health Technology |
Aziende private | 3 |
---|---|
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Finance |
SwanBio Therapeutics, Inc.
SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Danny Bar-Zohar